Search results for: 'more based system engineering iot bg data'

The value-based care (VBC) model aims to offer better outcomes and care quality to patients cost-effectively. Multiple stakeholders, including payers, healthcare providers, and medical technology (medtech) players, can share the revenue risk and incentive for providing better value. The United States is a pioneer in VBC adoption, followed by countr...

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...

In a highly competitive market with increasing regulatory pressures, Frost & Sullivan has analyzed the current state of the Internet of Medical Things (IoMT) security industry and presents the results of its research in this Frost Radar™, a benchmarking system to spark companies to action according to parameters of growth and innovation. The repo...

The convergence of IoT and healthcare, known as the internet of medical things (IoMT), is transforming the healthcare landscape, bringing unprecedented connectivity and convenience. However, the rapid proliferation of IoT devices in healthcare exposes critical data security and cybersecurity risks. This Frost & Sullivan study explores data security...

13 Jun 2023  |  North America  |  Market Research

US Healthcare Data Analytics, 2023

Competitive Intensity is Driving Innovation Among Healthcare Data Analytics Vendors

Infographics

×

This report offers a comprehensive analysis of the US healthcare data analytics market. The analysis focuses on solutions for payers and providers (including physician practices and hospitals). Solutions for the life sciences segment, pharmaceutical companies, and the public sector have been excluded. This study categorizes healthcare data analytic...

19 Aug 2022  |  North America  |  Frost Radar

Frost Radar™: Healthcare Data Analytics, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Healthcare organizations must be able to manage, analyze, and interpret data in order to identify strategic, tactical, and operational insights for decision making. This allows providers and payers to provide the best ways of delivering high-quality care. There has been a slow but steady change in the healthcare industry at the very core of its bus...

21 Dec 2023  |  North America  |  Market Research

Global Healthcare Data Interoperability Growth Opportunities Forecast to 2028

Systems to Move Beyond Integration Toward Semantic Interoperability

Infographics

×

Interoperability refers to the ability to exchange data among different systems or applications and make use of the incoming data. In healthcare, this generally means the ability to share data between electronic health record (EHR) systems and other health IT applications, such as a clinical decision support system (CDSS), computerized physician or...

11 Jun 2015  |  North America  |  Market Research

Analysis of the Western European Laboratory Information Management System Market

Cloud-based Technology and Increasing Need for Large Genetic and Molecular Testing Data Management to Drive the Market

Infographics

×

The research analyses the laboratory information management system (LIMS) market in Western Europe. It discusses the evolving market trends - the need for integration and the ever increasing sample data across labs in Western Europe. The study provides market overview, market engineering measurements, revenue forecasts, and company profiling. The s...

The COVID-19 pandemic impact on the biopharmaceutical industry has increased patient-centricity and the adoption of eClinical services digital platforms to manage clinical development programs. Capital investments and co-development recorded an uptick over the last 2 years, focusing on advancing clinical assets and expanding the number of Phase 2 a...